Navi
Right
 
Skip Navigation LinksHome Research report Pharma & Healthcare Diagnostics Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)
 
Social
Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)
Format : Pdf (Instant Download)
Date: 24, December 2018 | Pages: 101
Social
 
Electronic Access - Single User License
Tool
USD 1000
Electronic Access - Corporate User License
Tool
USD 1300
Hard Copy - Mail Delivery
Tool
USD 1100
 
   
 

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics (MD) is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

 

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market.

 

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market include progressing sample-to-answer molecular diagnostics market, growth in Point of Care Diagnostics (POCT), and emergence of Liquid Biopsy Solutions among others.

 

The report offers an in-depth analysis of the “Global Molecular Diagnostics Market”. It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies, of which Roche Holding AG, Abbott Laboratories, Danaher Corporation and Hologic Inc., have been covered in the report.
 

 

1. Overview

 

1.1 Diagnostics
1.2 Molecular Diagnostics
1.3 Purpose of Molecular Diagnostics

 

2. Global In-Vitro Diagnostics (IVD) Market

 

2.1 Global IVD Market by Value
2.2 Global IVD Market Forecast by Value
2.3 Global IVD Market by Segment
2.4 Global IVD Market by Technology

 

3. Global Molecular Diagnostics Market

 

3.1 Global Molecular Diagnostics Market by Value
3.2 Global Molecular Diagnostics Market Forecast by Value
3.3 Global Molecular Diagnostics Market by Application
3.3.1 Global Infectious Disease Testing Market by Value
3.3.2 Global Infectious Disease Testing Market Forecast by Value
3.3.3 Global Infectious Disease Testing Market Value by Type
3.3.4 Global CT/NG Market by Value & Volume
3.3.5 Global CT/NG Market Forecast by Value & Volume
3.3.6 Global HPV Testing Market by Value & Volume
3.3.7 Global HPV Testing Market Forecast by Value & Volume
3.3.8 Global Oncology Testing Market by Value
3.3.9 Global Oncology Testing Market Forecast by Value
3.3.10 Global Blood Screening Testing Market by Value
3.3.11 Global Blood Screening Testing Market Forecast by Value
3.3.12 Global Genetic Testing Market by Value
3.3.13 Global Genetic Testing Market Forecast by Value
3.4 Global Molecular Diagnostics Market by Technology
3.5 Global Molecular Diagnostics Market by Region

 

4. Regional Market Analysis

 

4.1 North America
4.1.1 North America Molecular Diagnostics Market by Value
4.1.2 North America Molecular Diagnostics Market Forecast by Value
4.1.3 North America Molecular Diagnostics Market by Application
4.1.4 North America Oncology Based Molecular Diagnostics Market by Value
4.1.5 North America Oncology Based Molecular Diagnostics Market Forecast by Value
4.1.6 North America Oncology Based Molecular Diagnostics Market by Product
4.1.7 North America Oncology Based Reagents Market by Value
4.1.8 North America Oncology Based Reagents Market Forecast by Value
4.1.9 North America Oncology Based Instruments Market by Value
4.1.10 North America Oncology Based Instruments Market Forecast by Value

 

4.2 Western Europe
4.2.1 Western Europe Molecular Diagnostics Market by Value
4.2.2 Western Europe Molecular Diagnostics Market Forecast by Value
4.2.3 Western Europe Molecular Diagnostics Market by Application

 

4.3 Asia Pacific
4.3.1 Asia Pacific Molecular Diagnostics Market by Value
4.3.2 Asia Pacific Molecular Diagnostics Market Forecast by Value
4.3.3 Asia Pacific Molecular Diagnostics Market by Application

 

5. Market Dynamics

 

5.1 Growth Drivers
5.1.1 Fast Approvals for Companion Diagnostics (CD) Reagents
5.1.2 Rising Emergence of Infectious Diseases
5.1.3 Rise in Global Ageing Population
5.1.4 Increasing Incidence of Cancer Cases
5.1.5 Rising Global Healthcare Expenditure

 

5.2 Key Trends and Developments
5.2.1 Progressing Sample-to-Answer Molecular Diagnostics Market
5.2.2 Growth in Point of Care Diagnostics (POCT)
5.2.3 Booming Medical Devices Industry
5.2.4 Innovation and Technical Developments
5.2.5 Emergence of Liquid Biopsy Solutions
5.2.6 Targeting Anti-Biotic Resistance
5.2.7 Decentralization of Diagnostic Testing

 

5.3 Challenges
5.3.1 High Initial Cost
5.3.2 Obligation Of Skilled Labor
5.3.3 Urgent Need for Proper Infrastructure

 

6. Competitive Landscape

 

6.1 Global IVD Market
6.1.1 Global IVD Kit Market Share by Company
6.2 Global Molecular Diagnostics Market
6.2.1 Global Molecular Diagnostics Market Share by Company
6.2.2 Global Infectious Disease Testing Market Share by Company
6.2.3 Global Blood Screening Testing Market Share by Company
6.2.4 Revenue and Market Cap Comparison

 

7. Company Profiles

 

7.1 Roche Holding AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies

 

7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies

 

7.3 Danaher Corporation
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies

 

7.4 Hologic Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies

 

List of Charts

 

IVD Market – Segments by Technology
Molecular Diagnostics – Traditional Process
Molecular Diagnostics Breakdown
Main Purposes of Molecular Diagnostics
Global IVD Market by Value (2013-2017)
Global IVD Market Forecast by Value (2018-2022)
Global IVD Market by Segment (2017)
Global IVD Market CAGR by Technology (2013-2017)
Global Molecular Diagnostics Market by Value (2013-2017)
Global Molecular Diagnostics Market Forecast by Value (2018-2022)
Global Molecular Diagnostics Market by Application (2017)
Global Infectious Disease Testing Market by Value (2013-2017)
Global Infectious Disease Testing Market Forecast by Value (2018-2022)
Global Infectious Disease Testing Market Value by Type (2017)
Global CT/NG Market by Value & Volume (2013-2017)
Global CT/NG Market Forecast by Value & Volume (2018-2022)
Global HPV Market by Value & Volume (2013-2017)
Global HPV Market Forecast by Value & Volume (2018-2022)
Global Oncology Testing Market by Value (2013-2017)
Global Oncology Testing Market Forecast by Value (2018-2022)
Global Blood Screening Testing Market by Value (2013-2017)
Global Blood Screening Testing Market Forecast by Value (2018-2022)
Global Genetic Testing Market by Value (2013-2017)
Global Genetic Testing Market Forecast by Value (2018-2022)
Global Molecular Diagnostics Market by Technology (2017)
Global Molecular Diagnostics Market by Region (2017)
North America Molecular Diagnostics Market by Value (2013-2017)
North America Molecular Diagnostics Market Forecast by Value (2018-2022)
North America Molecular Diagnostics Market by Application (2017)
North America Oncology Based Molecular Diagnostics Market by Value (2013-2017)
North America Oncology Based Molecular Diagnostics Market Forecast by Value (2018-2022)
North America Oncology Based Molecular Diagnostics Market by Product (2017)
North America Oncology Based Reagents Market by Value (2013-2017)
North America Oncology Based Reagents Market Forecast by Value (2018-2022)
North America Oncology Based Instruments Market by Value (2013-2017)
North America Oncology Based Instruments Market Forecast by Value (2018-2022)
Western Europe Molecular Diagnostics Market by Value (2013-2017)
Western Europe Molecular Diagnostics Market Forecast by Value (2018-2022)
Western Europe Molecular Diagnostics Market by Application (2017)
Asia Pacific Molecular Diagnostics Market by Value (2013-2017)
Asia Pacific Molecular Diagnostics Market Forecast by Value (2018-2022)
Asia Pacific Molecular Diagnostics Market by Application (2017)
Worldwide Ageing Population 60 Years or Older (2000-2030E)
Global Cancer Prevalence (2016-2021)
Global Healthcare Expenditure Per Capita (2013-2017)
Global Sample-to-Answer Molecular Diagnostics Market Value (2013-2017)
Global POCT Device Sales (2012-2017)
Global IVD Kit Market Share by Company (2017)
Global Molecular Diagnostics Market Share by Company (2017)
Global Infectious Disease Testing Market Share by Company (2017)
Global Blood Screening Testing Market Share by Company (2017)
Roche Sales by Segments (2017)
Roche Sales and Net Income (2013-2017)
Abbott Laboratories Sales by Segment (2017)
Abbott Laboratories Net Sales and Net Earnings (2013-2017)
Abbott Laboratories R&D Expenditure (2015-2017)
Danaher Corp. Revenue by Segments (2017)
Danaher Corp. Revenue and Net Earnings (2013-2017)
Danaher Corp. R&D Expenditure (2015-2017)
Hologic’s Revenue by Business Segments (2018)
Hologic Inc. Revenue and Net Income (2014-2018)
Hologic Inc. R&D Expenditure (2016-2018)

 

List of Tables

 

The US approvals for CD Reagents
Growing Cases and Prevalence of STDs in the US (2010-2017)
Global Medical Equipment/Devices Sales (2016/2022)
Key Players - Revenue & Market Cap Comparison (2017)
Roche Agreements (2017/2018)
Roche Product Approvals (2018)
Hologic Inc. Product Launches (2018)

 

One can also purchase any particular sections from this report. Please send us an email to info@konceptanalytics.com with your order details.
 
RELATED reports
 
Date: January 15,2014 | Pages: 60 | Price : $800 | Format : Pdf (Instant Download)
Date: July 11,2013 | Pages: 57 | Price : $800 | Format : Pdf (Instant Download)
Date: February 28,2013 | Pages: 45 | Price : $800 | Format : Pdf (Instant Download)
Date: September 27,2012 | Pages: 48 | Price : $800 | Format : Pdf (Instant Download)
Date: March 24,2014 | Pages: 54 | Price : $800 | Format : Pdf (Instant Download)
Date: July 22,2014 | Pages: 59 | Price : $800 | Format : Pdf (Instant Download)
Date: January 29,2015 | Pages: 64 | Price : $800 | Format : Pdf (Instant Download)
Date: June 15,2015 | Pages: 48 | Price : $700 | Format : Pdf (Instant Download)
Date: July 27,2015 | Pages: 62 | Price : $800 | Format : Pdf (Instant Download)
Date: December 7,2016 | Pages: 81 | Price : $800 | Format : Pdf (Instant Download)
Date: October 6,2017 | Pages: 90 | Price : $900 | Format : Pdf (Instant Download)
Date: July 20,2018 | Pages: 67 | Price : $1000 | Format : Pdf (Instant Download)
Date: September 19,2018 | Pages: 82 | Price : $900 | Format : Pdf (Instant Download)
Date: September 28,2018 | Pages: 76 | Price : $800 | Format : Pdf (Instant Download)
 
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.